Results 281 to 290 of about 924,903 (427)

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen   +7 more
wiley   +1 more source

Prepregnancy overweight and obesity and the risk of adverse pregnancy outcomes. [PDF]

open access: yesSci Rep
Abdi F   +6 more
europepmc   +1 more source

Discovering new hub genes of dilated cardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Dilated cardiomyopathy (DCM) has a poor prognosis and exhibits a complex and diverse aetiology and genetic profile. The genes responsible for the pathogenesis of DCM have not been fully identified. The present study aimed to explore new hub genes of DCM by mining the human DCM databases and further by experimental validation.
Jun‐Yan Zhu   +9 more
wiley   +1 more source

The Epidemiologic Study to Reasses “Overweight” in 15year-old Students

open access: bronze, 1997
高須 好美   +16 more
openalex   +2 more sources

Acute myocarditis according to age: Presentation, management and early outcomes

open access: yesESC Heart Failure, EarlyView.
MIS, multisystem inflammatory syndrome; MRE, myocarditis‐related events (within 30 days included all‐cause death, cardiogenic shock, cardiac arrest, ventricular arrhythmias or complete AV block). Abstract Aims Acute myocarditis (AM) is a rare but severe disease affecting patients of all ages. Large multicentric studies comparing children and adults are
Clément Karsenty   +25 more
wiley   +1 more source

Early supplement of probiotics reduces the risk of obesity among preschool children: a real-world observational study. [PDF]

open access: yesFront Nutr
Zhang M   +13 more
europepmc   +1 more source

SERTRALINE, A SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR, RESULTS IN WEIGHT LOSS AND AN INCREASED 24-HOUR ENERGY EXPENDITURE IN TRAINED AND UNTRAINED OVERWEIGHT WOMEN 515

open access: bronze, 1996
Karly M. Murphy   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy